Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial
PRV-101(一种针对与1型糖尿病相关的柯萨奇B病毒(CVB)的多价疫苗)的安全性、耐受性和免疫原性:一项双盲随机安慰剂对照I期试验
期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-024-06092-w
Hyöty, Heikki; Kääriäinen, Susanna; Laiho, Jutta E; Comer, Gail M; Tian, Wei; Härkönen, Taina; Lehtonen, Jussi P; Oikarinen, Sami; Puustinen, Leena; Snyder, Michele; León, Francisco; Scheinin, Mika; Knip, Mikael; Sanjuan, Miguel